54 related articles for article (PubMed ID: 898800)
1. [Immunologic reactions in cervical cancer].
Gorodilova VV; Iatskovskaia NL
Vopr Onkol; 1977; 23(3):9-12. PubMed ID: 898800
[TBL] [Abstract][Full Text] [Related]
2. [Immunological reactivity of the body in cancer of the corpus uteri].
Gorodilova VV; Iatskovskaia NL
Vopr Onkol; 1978; 24(3):10-3. PubMed ID: 644958
[TBL] [Abstract][Full Text] [Related]
3. [A study on the correlation between immune responses and histopathological changes of primary lesion in patients with cervical cancer following radiation therapy (author's transl)].
Shiozawa I
Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1986-94. PubMed ID: 7211216
[TBL] [Abstract][Full Text] [Related]
4. [Skin tests as immunologic parameters in cervical cancer].
Wagner G
Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
[TBL] [Abstract][Full Text] [Related]
5. Demonstration of tumor-associated delayed cutaneous hypersensitivity reactions in patients with lung cancer and in pateients with carcinoma of the cervix.
Wells SA; Burdick JF; Christiansen C; Ketcham AS; Adkins PC
Natl Cancer Inst Monogr; 1973 Jun; 37():197-203. PubMed ID: 4713780
[No Abstract] [Full Text] [Related]
6. [Immunity indices in patients with cancer of the uterine body treated with 17-alpha-oxyprogesterone-capronate].
Iatskovskaia NL
Vopr Onkol; 1979; 25(10):53-5. PubMed ID: 506182
[TBL] [Abstract][Full Text] [Related]
7. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunologic study of patients of cancer cervix.
Sharma D; Gupta RM; Kadian V
Indian J Med Res; 1979 Nov; 70():793-800. PubMed ID: 535976
[No Abstract] [Full Text] [Related]
9. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Santin AD; Bellone S; Palmieri M; Ravaggi A; Romani C; Tassi R; Roman JJ; Burnett A; Pecorelli S; Cannon MJ
Gynecol Oncol; 2006 Mar; 100(3):469-78. PubMed ID: 16249018
[TBL] [Abstract][Full Text] [Related]
10. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
11. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the immune status of patients with operated and irradiated cervical and breast cancer. III. Comparative investigation of the immune status of patients with breast cancer treated by operation and irradiation and of patients with cervical cancer treated either by operation or irradiation (author's transl)].
Palencia C; Wicke L; Kärcher KH; Gitsch E; Hernuss P; Steffen C
Wien Klin Wochenschr; 1976 Aug; 88(15):495-501. PubMed ID: 997530
[TBL] [Abstract][Full Text] [Related]
13. Delayed cutaneous hypersensitivity reactions to tumor extracts in patients with cervical carcinoma.
Melewicz FC; Wells SA; Christiansen C; Ketcham A
Surg Forum; 1972; 23(0):94-6. PubMed ID: 4671036
[No Abstract] [Full Text] [Related]
14. Antigen specific stimulation of immune responses during long-term repeated skin testing with multiple antigens.
Lesourd BM; Winters WD; Darnell B
J Clin Lab Immunol; 1986 Sep; 21(1):17-22. PubMed ID: 2433448
[TBL] [Abstract][Full Text] [Related]
15. Frequency of antibody to a virus-induced tumor-associated antigen (AG-4) in Japanese sera from patients with cervical cancer and controls.
Kawana T; Cornish JD; Smith MF; Aurelian L
Cancer Res; 1976 Jun; 36(6):1910-4. PubMed ID: 1268845
[TBL] [Abstract][Full Text] [Related]
16. [Determination of circulating immune complexes and associated parameters in patients with cervix uteri cancer].
Orozco-Cruz R; Aguilar-Santelises M; Rodríguez-Coquiez G; Estrada Parra S
Rev Latinoam Microbiol; 1987; 29(2):145-51. PubMed ID: 3438604
[No Abstract] [Full Text] [Related]
17. Occurrence of lactosylsphingosine-reactive antibodies in sera of cancer patients.
Jóźwiak W; Kościelak J
Acta Haematol Pol; 1980; 11(3):173-9. PubMed ID: 7445920
[No Abstract] [Full Text] [Related]
18. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
19. Letter: Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Forman SJ; Hall TC
Surg Gynecol Obstet; 1974 Jan; 138(1):83. PubMed ID: 4855577
[No Abstract] [Full Text] [Related]
20. No difference in delayed hypersensitivity between breast and cervical carcinomas.
Munzarová M; Kovarík J; Ptácková B; Hlávková J; Kolcová V; Nebeský T
Neoplasma; 1984; 31(1):95-8. PubMed ID: 6700799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
